Follow the Alembic Pharmaceuticals Limited share price and the full management transaction log of the company, a listed issuer based in India. Shares trade on IN IN, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Alembic Pharmaceuticals Limited has logged 34 public disclosures. Market capitalisation: €148.3bn. The latest transaction was reported on 30 September 2025 (Purchase). Among the most active insiders: Chirayu Ramanbhai Amin HUF. Every trade is accessible without an account.
34
Insider Decl.
0
Thresholds
€5m
32 ops.
Buy Volume
·
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Alembic Pharmaceuticals Limited Buy (bullish), based on 10 analysts. Average price target: ₹907.20.
18Σ signal
Buys €5m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 5,654 of 25,571 companies
65.8
score / 100
Value
56
Quality
75
FCF yld1.9%
Earn yld4.5%
EV/EBITDA·
ROE12%
Gross mgn73%
Net mgn9.2%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.